Chinese English Germany Japanese

Guangzhou Weiaokang Pharmaceutical Technology Co., Ltd회사는 제품 목록을 제공합니다.

회사 명:Guangzhou Weiaokang Pharmaceutical Technology Co., Ltd
전화:-
이메일:pengguizi@cti-cert.com
국적:China
URL:
총 제품 수:150
1 2

제품 카탈로그

Erlotinib hydrochloride; PhEur/USP(DMF)183319-69-9C22H24ClN3O4
1,2,4-Triazolo[4,3-a]pyridin-3(2H)-one; PhEur/USP(DMF)6969-71-7C6H5N3O
Sunitinib Malate; PhEur/USP(DMF)341031-54-7C26H33FN4O7
Pomalidomide; PhEur/USP(DMF)19171-19-8C13H11N3O4
Avibactam INT 1; PhEur/USP(DMF)1416134-48-9C17H24N2O7
1-(3-chlorophenyl)-4-(3-chloropropyl)piperazine hydrochloride; PhEur/USP(DMF)1-(3-클로로페닐)-4-(3-클로로프로필)피페라진염산염52605-52-4C13H19Cl3N2
Methylene Blue; PhEur/USP(DMF)메틸렌블루61-73-4C16H18ClN3S
2-(3-bromo-4,5-dimethoxyphenyl)ethan-1-amine hydrochloride; PhEur/USP(DMF)92015-18-4C10H14BrNO2.ClH
Crizotinib; PhEur/USP(DMF)크리조티닙877399-52-5C21H22Cl2FN5O
ETHYL 4-METHOXYBENZOYLACETATE; PhEur/USP(DMF)에틸4-메톡시벤조일아세테이트2881-83-6C12H14O4
Olaparib; PhEur/USP(DMF)올라파립763113-22-0C24H23FN4O3
Ruxolitinib; PhEur/USP(DMF)룩소리티닙941678-49-5C17H18N6
Osimertinib; PhEur/USP(DMF)1421373-65-0C28H33N7O2
Dexpanthenol Impurity2(R)-2,4-디히드록시-3,3-디메틸부티르산나트륨염C{6}H{11}NaO{4}
Trametinib Impurity 14
Atrasentan  Impurity 27
Quisinostat Impurity4
Baricitinib  Impurity 6C12H19N3O2Si
Baricitinib  Impurity 3
Atrasentan  Impurity 23
Quisinostat Impurity3
Trametinib Impurity 15329941-39-1C15H16N2O3S
Atrasentan  Impurity 22
Trametinib Impurity 01
Atrasentan  Impurity 25
Quisinostat Impurity1
Baricitinib  Impurity 2
Trametinib Impurity 02871700-28-6C13H11FIN3O2
Trametinib Impurity 12871700-24-2C18H15FIN3O4
Trametinib Impurity 10
Atrasentan  Impurity 21
Trametinib Impurity 07
Quisinostat Impurity6
Baricitinib  Impurity 5
Dexpanthenol Impurity1D-펜토락톤C6H10O3
Atrasentan  Impurity 19
Quisinostat Impurity2
Atrasentan  Impurity 18
Trametinib Impurity 04
Atrasentan  Impurity 20
Atrasentan  Impurity 28
Atrasentan  Impurity 26
Trametinib Impurity 08
Trametinib Impurity 03871700-30-0C16H16FIN4O2
Dexpanthenol Impurity3C10H19NO5
Baricitinib  Impurity 4
Trametinib Impurity 13871700-32-2C25H21FIN3O6S
Trametinib Impurity 17871700-65-1C26H24FN5O4
Baricitinib  Impurity 7
Trametinib Impurity 20871701-23-4C26H23FIN5O4
Quisinostat Impurity8
Trametinib Impurity 11871700-25-3C26H23FIN5O4
Quisinostat Impurity7
Quisinostat Impurity5
Baricitinib  Impurity 1C15H15N7O2S
Trametinib Impurity 21871701-87-0C24H21FIN5O3
Trametinib Impurity 193018911-27-5C17H17FIN3O3
Atrasentan  Impurity 24
Trametinib Impurity 06
Trametinib Impurity 18
Trametinib Impurity 16C26H23FIN5O5
Ethyl 4-(ethoxycarbonyl)piperidine-1-acetate에틸4-(에톡시카르보닐)피페리딘-1-아세테이트1838-39-7C12H21NO4
LenalidoMide; PhEur/USP(DMF)레날리도마이드191732-72-6C13H13N3O3
4-chloro-7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidine; PhEur/USP(DMF)941685-26-3C12H18ClN3OSi
lenvatinib Mesylate; PhEur/USP(DMF)렌바티닙메실레이트857890-39-2C22H23ClN4O7S
Trazodone hydrochloride; PhEur/USP(DMF)트라조돈 히드로 클로라이드25332-39-2C19H23Cl2N5O
5-BROMOVERATRALDEHYDE; PhEur/USP(DMF)5-브로모베라트랄디하이드6948-30-7C9H9BrO3
tert-butyl 4-((1R,2S,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamido)piperidine-1-carboxylate; PhEur/USP(DMF)1174020-63-3C24H34N4O5
1,3-Benzodioxole,5-[(1E)-2-nitroethenyl]-; PhEur/USP(DMF)22568-48-5C9H7NO4
Methylene Blue trihydrate; PhEur/USP(DMF)메틸렌 블루, 트리수화물7220-79-3C16H20ClN3OS
Dasatinib; PhEur/USP(DMF)다사티닙302962-49-8C22H26ClN7O2S
(2S,3S,4R)-ethyl 4-(benzo[d][1,3]dioxol-5-yl)-2-(4-methoxyphenyl)pyrrolidine-3-carboxylate; PhEur/USP(DMF)173937-93-4C21H23NO5
ethyl 3-(benzo[d][1,3]dioxol-5-yl)-2-(4-methoxybenzoyl)-4-nitrobutanoate; PhEur/USP(DMF)173864-45-4C21H21NO8
(S)-(-)-Verapamilic Acid; PhEur/USP(DMF)(S)-(-)-베라파밀산36622-24-9C16H21NO4
1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole; PhEur/USP(DMF)1029716-44-6C13H23BN2O3
tert-butyl 4-((2S,5R)-5-(benzyloxyamino)piperidine-2-carboxamido)piperidine-1-carboxylate 4-methylbenzenesulfonate; PhEur/USP(DMF)1510832-19-5C23H36N4O4
Papaverine hydrochloride; PhEur/USP(DMF)61-25-6C20H22ClNO4
atrasentan; PhEur/USP(DMF)아트라센탄173937-91-2C29H38N2O6
Sorafenib tosylate; PhEur/USP(DMF)475207-59-1C21H16ClF3N4O3.C7H8O3S
1-(3,4-dimethoxybenzyl)-3,4-dihydro-6,7-dimethoxyisoquinolinium chloride; PhEur/USP(DMF)1-(3,4-디메톡시벤질)-3,4-디하이드로-6,7-디메톡시이소퀴놀리늄클로라이드5884-22-0C20H24ClNO4
Tofacitinib citrate; PhEur/USP(DMF)540737-29-9C16H20N6O.C6H8O7
GSK1120212 (DMSO solvate); PhEur/USP(DMF)1187431-43-1C28H29FIN5O5S
N-(3,4-dimethoxyphenethyl)-2-(3,4-dimethoxyphenyl)acetamide; PhEur/USP(DMF)139-76-4C20H25NO5
Nilotinib Hydrochloride; PhEur/USP(DMF)무수닐로티닙염산염923288-95-3C28H23ClF3N7O
N,N-dibutyl-2-chloro-Acetamide; PhEur/USP(DMF)2567-59-1C10H20ClNO
3-(2-Aminoethyl)benzoic acid methyl ester HCl; PhEur/USP(DMF)3-(2-아미노에틸)벤조산메틸에스테르HCl167846-36-8C10H14ClNO2
Atrasentan hydrochloride; PhEur/USP(DMF)195733-43-8C29H38N2O6.HCl
Trans-5-(Benzyloxyamino)piperidine-2-carboxylic acid; PhEur/USP(DMF)1501980-29-5C13H18N2O3
methyl (2R,3R,4S)-4-(benzo[d][1,3]dioxol-5-yl)-2-(4-methoxyphenyl)pyrrolidine-3-carboxylate; PhEur/USP(DMF)250583-09-6C20H21NO5
2-(1-(ethylsulfonyl)-3-(4-(7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile; PhEur/USP(DMF)1187594-13-3C22H31N7O3SSi
Aceclidine hydrochloride; PhEur/USP(DMF)6109-70-2C9H16ClNO2
3-Quinuclidinone hydrochloride; PhEur/USP(DMF)3-퀴누클리돈 하이드로클로라이드1193-65-3C7H12ClNO
3-Pyrrolidinecarboxylic acid, 4-(1,3-benzodioxol-5-yl)-2-(4-methoxyphenyl)-, (2R,3R,4S)-, (αS)-α-hydroxybenzeneacetate (9CI); PhEur/USP(DMF)195529-63-6C27H27NO8
Alectinib; PhEur/USP(DMF)알렉티닙1256580-46-7C30H34N4O2
2-[1-(ethylsulfonyl)azetidin-3-ylidene]acetonitrile; PhEur/USP(DMF)2-(1-(에틸술포닐)아제티딘-3-일리덴)아세토니트릴1187595-85-2C7H10N2O2S
(2S,5R)-2-carbamoyl-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl sulfate; PhEur/USP(DMF)1174020-64-4C17H28N4O5
(R)-(+)-Verapamilic Acid; PhEur/USP(DMF)(R)-(+)-베라파밀산38175-99-4C16H21NO4
Imatinib mesylate; PhEur/USP(DMF)220127-57-1C30H35N7O4S
Methylene blue ; PhEur/USP(DMF)122965-43-9C16H20ClN3OS
Ceritinib (LDK378); PhEur/USP(DMF)세리티닙1032900-25-6C28H36ClN5O3S
1 2
Copyright 2019 © ChemicalBook. All rights reserved